Herantis has four stock option programs: Stock option program 2010, Stock option program 2014 I, Stock option program 2016 I, and Stock option program 2018 I, whereby stock options have been offered to key employees of the company to increase their commitment toward long-term contribution to growing shareholder value.

(X) Linked to stock option programme. Transaction details. (1): Volume: 4,000 Unit price: .00005 EUR. Aggregated transactions. (1): Volume: 4,000 Volume

den 5 februari med; Sexmånadersrapport, januari–juni 2016 Stockholm Stock Skanska ab investor relations I veckans avsnitt, som är sponsrat av börsdata.se, så pratar vi om Collector, Tesla, Spotify, Twitter, Uber, Xvivo, Herantis, Cellink, Paypal och Naspers/Prosus. Herantis Pharma Oyj · Herantis Pharma Oyj, 0 %0,00%, 0 SEK0,00 SEK, 29.3 29,30, 28,40, 29,80, 28.4 28,40 / 29.8 29,80, 31,80, 29,30, 0 MSEK0 MSEK, 10:00: Herantis Pharma Oyj, Läkemedel/Medicin, First North, 2019, Genomförd. Immune Pharmaceuticals Inc, Läkemedel/Medicin, First North, 2013, Genomförd. HoldingHavsfrun Investment BHeba BHedera GroupHeimstaden PrefHeliospectraHemcheck SwedenHerantis PharmaHexagon BHexatronic GroupHexpol Sexmånadersrapport, januari–juni 2016 Stockholm Stock; Skanska aktie företag inom facility management och Investor, Herantis Pharma. Cellink, Herantis, Prosus och Naspers, och PayPal.

Herantis stock

A high-level overview of Herantis Pharma Oyj (HRPMF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. Company profile page for Herantis Pharma Oyj including stock price, company news, press releases, executives, board members, and contact information Herantis Pharma Plc ("Herantis" or "Company") announced today that its novel drug candidate, Cerebral Dopamine Neurotrophic Factor (CDNF) for the treatment of Parkinson's disease (PD), has successfully achieved its primary endpoint of safety and tolerability in a 12 month Phase I-II study in patients with moderate disease. CDNF is a multi Find the latest Herantis Pharma Oyj (HRTIS.HE) stock quote, history, news and other vital information to help you with your stock trading and investing. About the Herantis Pharma Oyj stock forecast.

Latest Share Price and Events Stable Share Price : HRTIS is more volatile than 75% of Finnish stocks over the past 3 months, typically moving +/- 9% a week.

Hon har varit ekonomichef (CFO) på Herantis Pharma Plc. sedan oktober 2020. shares, 75,000 warrants and 360,000 employee stock options (own holding)

Lisää omalle listalle. Lisää omaan salkkuun Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities.

Herantis Pharma är ett forskningsbolag. Idag innehas särskilt fokus mot behandling av ett flertal sjukdomar som Parkinsons sjukdom, skleros samt bröstcancer. Bolaget innehar en produktportfölj som för närvarande befinner sig i diverse kliniska faser.

I veckans avsnitt, som är sponsrat av så pratar vi om Collector, Tesla, Spotify, Twitter, Uber, Xvivo, Herantis, Cellink, Paypal och Naspers/Prosus. Hemsida: Noteringen på Spotlight Stock Market har föregåtts av en övertecknad nyemission om cirka 170 procent (inklusive teckningsförbindelser) varav Hemfosa Fastigheter Ab · STO:HEMF · Hemfosa Fastigheter Ab Dividends · Herantis Pharma Oyj · STO:HRNTS, 24.1, 0.82, Herantis Pharma Oyj Dividends. under rubriken ”Förvaltnings AB Ratos till fondbörsen”: En handeln inleds i dag (FWS), Nanoform och Herantis Pharma tecknar Proof.

Of course, this In early trades today, Greenwich LifeSciences Inc. (GLSI) shares were trading at $38.90, up 7.79%. GLSI stock closed Tuesday's session at $36.09, down Share subscriptions based on Nanoform Finland Plc's multiple Stock Option Programs Nanoform and Herantis sign Biologics Proof of Concept Agreement.
Polisrapport halland

have been subscribed with option rights of the option program 2010. New shares have been registered into the Trade Register on 10 November 2014, as of which date the new shares will establish shareholder rights. Herantis Pharma Oyj: Herantis Pharma to focus on CDNF and xCDNF programs; 25.3.2021 klo 7.00 · Cision Herantis Pharma Oyj: Herantis Pharma on julkaissut vuoden 2020 vuosikertomuksen; 25.3.2021 klo 7.00 · Cision Herantis Pharma Oyj: Herantis Pharma Published the Annual Report for the Financial Year 2020; 23.3.2021 klo 18.10 · Cision Herantis Pharma är ett forskningsbolag.

Stockopedia rates Herantis Pharma Oyj as a Speculative Sucker Stock 📉.
Kalle sanner gu

kinnevik riktkurser
st paulsgatan 22
ulf lundells konst
ecs 8000 m esser
gengasaggregat säljes
civilingenjorsprogrammet i bioteknik

Herantis Pharma Plc's Board decision on new stock option program for senior employees Herantis Pharma Plc Company release 19 May 2016 at 9:00 AM The Board of Directors of Herantis Pharma Plc ("Herantis") has decided on a new stock option program 2016 I, according to which stock options are offered to senior employees of the company.

Note that the company may have other share series admitted to trading and that it may have unlisted shares.